Has Jonathan King, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,637 in general payments to Jonathan King, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan King, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan King, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan King, MD

Otolaryngology · Lexington, SCNPI 1811938830

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 61.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $1,984 and has fallen 88.0% since, to $239 in 2025.

$3,637in general payments, 2019–2025

Across 65 payments — averaging $55.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Optinose US, Inc.$555
Sanofi$268
Regeneron Healthcare Solutions, Inc.$120
Aerin Medical Inc.$91
GSK$49
plus $318 from 10 others

$48,641in research payments, 2019–2025

Across 1 payment — averaging $48,641 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Livanova USA, Inc.$49K

What the payments were for

Travel & lodging$1,44440%
Food & beverage$2,09458%
Education$983%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	7	$2,236
Optinose US, Inc.	26	$555
Sanofi	8	$268
Regeneron Healthcare Solutions, Inc.	2	$120
Aerin Medical Inc.	4	$91
GSK	3	$49
Kerecis Limited	1	$47
Alk-abello, Inc	2	$41
Amgen	2	$39
Integra Lifesciences Corporation	2	$35
Hikma Pharmaceuticals USA	2	$35
Medtronic	2	$32
Novartis	1	$28
Acclarent, Inc	1	$27
Smith+Nephew	1	$20
Intersect ENT, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$2,095
Xhance$118

How this compares

$3,637 in reported general payments places this provider in the 75th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$183,044

Medicare patients

437

Services billed

2,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	15	$57,938
Famotidine	114	$1,436
Ipratropium Bromide	40	$1,301
Fluticasone Propionate	61	$950
Montelukast Sodium	45	$710
Clarithromycin	14	$494
Omeprazole	28	$403
Lansoprazole	12	$296
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	32	$246
Gabapentin	16	$242
Azithromycin	20	$166
Mupirocin	29	$156
Levothyroxine Sodium	18	$131
Hydroxyzine Pamoate	13	$121
Pantoprazole Sodium	11	$120

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lexington

Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Peter HorwichNorth Charleston$33K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K
Alexandra KejnerCharleston$19K
Evan GraboyesCharleston$18K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →